Why is Welcure Drugs falling/rising?

As of 05-Sep, Welcure Drugs & Pharmaceuticals Ltd is experiencing a price increase, currently at 9.81, which reflects a rise of 0.31 or 3.26%. The stock has shown a positive trend recently, gaining for the last three days with a total return of 11.6% during this period. Additionally, it has outperformed its sector by 3.33%. The company has reported outstanding results in its latest financials, including a staggering 1314% growth in net sales and a 2184.3% increase in profit after tax compared to the previous quarter's average. However, it also faces challenges, such as poor management efficiency indicated by a low return on equity of 3.58%, which may affect investor confidence.
In the broader market context, the stock's short-term performance over the past week shows a return of +0.82%, which is slightly below the benchmark Sensex's return of +1.13%. Year-to-date, the stock has underperformed significantly with a decline of 15.94%, while the Sensex has gained 3.29%. Despite these challenges, the recent positive financial results and rising investor participation suggest a potential turnaround, although the overall long-term performance remains a concern given the stock's substantial decline over the past year.